Compute & Embodied AI Portfolio

Tail
Created by Wei
My Compute & Embodied AI portfolio is up after several months. If anything's offside, propose a rebalance. Hold the orders until I sign off.

I'll dig into the Compute & Embodied AI account. Let me pull the current state and mandate first.

Strong run, Wei. +42% on the account. Let me verify current prices (US pre-market now) and check the concentration math before proposing anything.

Market's closed (Monday pre-market, 07:25 ET); prices below are Friday's close. Here's where the account stands.

Compute & Embodied AI — Scorecard

Equity $1.24M, up +42.1% (+$236.5K). Here's each position against your mandate limits:

PositionMkt ValueWeightP&Lvs 15% cap
ARM$316.1K25.4%+215.9%🔴 BREACH
VRT$168.1K13.5%+12.1%
NVDA$125.2K10.1%+12.0%
TSLA$121.9K9.8%+1.8%
SYM$66.6K5.4%−16.5%
Cash$445.8K35.8%floor is 10–15%

What's offside

One hard breach: ARM at 25.4%, way over your 15% single-position cap. Your monster +216% winner has compounded itself into a concentration risk. At its allowed 40% single-stock drawdown, ARM alone could knock ~10% off the whole account. This is a discipline trim, not a thesis change, the edge-AI architecture story is intact.

Two soft items (not violations, but worth flagging):

  • Cash at 35.8% is more than double your floor. You're heavily under-deployed for a mandate that's running hot.
  • 5 holdings vs the 8–10 the playbook calls for. Thin diversification, which is exactly why ARM's run dominated the book.

Proposed trim (the only mandate-required action)

Sell 360 ARM @ market → leaves 470 shares (~$179K, 14.4%), a hair under the cap for buffer. Frees ~$137K.

That's the clean de-risk. The catch: it pushes cash to ~$583K (47%), even more under-deployed. So the real question is direction:

  • Path A — De-risk only: Just trim ARM, sit on cash, wait for a setup. Simplest.
  • Path B — Trim + redeploy to mandate: Trim ARM and put part of the cash into 2–3 new embodied-AI/robotics names to get you toward 8–10 holdings and cash back near 15%. I'd need to source candidates that pass your multi-factor screen (valuation + catalyst + technicals aligned).

SYM is your only loser (−16.5%) but it's small and nowhere near the 40% stop, so I'd hold and watch, not act.

Which path, Wei? Confirm and I'll stage the orders, nothing submitted until you sign off. If Path B, I'll bring you a candidate shortlist first.